Potential involvement of IL-17F in asthma

Kyoko Ota, Mio Kawaguchi, Satoshi Matsukura, Masatsugu Kurokawa, Fumio Kokubu, Junichi Fujita, Yuko Morishima, Shau Ku Huang, Yukio Ishii, Hiroaki Satoh, Nobuyuki Hizawa

Research output: Contribution to journalReview article

26 Citations (Scopus)

Abstract

The expression of IL-17F is seen in the airway of asthmatics and its level is correlated with disease severity. Several studies have demonstrated that IL-17F plays a pivotal role in allergic airway inflammation and induces several asthma-related molecules such as CCL20. IL-17F-induced CCL20 may attract Th17 cells into the airway resulting in the recruitment of additional Th17 cells to enhance allergic airway inflammation. We have recently identified, for the first time, that bronchial epithelial cells are its novel cell source in response to IL-33 via ST2-ERK1/2-MSK1 signaling pathway. The receptor for IL-17F is the heterodimeric complex of IL-17RA and IL-17RC, and IL-17F activates many signaling pathways. In a case-control study of 867 unrelated Japanese subjects, a His161 to Arg161 (H161R) substitution in the third exon of the IL-17F gene was associated with asthma. In atopic patients with asthma, prebronchodilator baseline FEV1/FVC values showed a significant association with the H161R variant. Moreover, this variant is a natural antagonist for the wild-type IL-17F. Moreover, IL-17F is involved in airway remodeling and steroid resistance. Hence, IL-17F may play an orchestrating role in the pathogenesis of asthma and may provide a valuable therapeutic target for development of novel strategies.

Original languageEnglish
Article number602846
JournalJournal of Immunology Research
Volume2014
DOIs
Publication statusPublished - Jan 1 2014
Externally publishedYes

Fingerprint

Interleukin-17
Asthma
Th17 Cells
Inflammation
Airway Remodeling
Case-Control Studies
Exons
Epithelial Cells
Steroids

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Ota, K., Kawaguchi, M., Matsukura, S., Kurokawa, M., Kokubu, F., Fujita, J., ... Hizawa, N. (2014). Potential involvement of IL-17F in asthma. Journal of Immunology Research, 2014, [602846]. https://doi.org/10.1155/2014/602846

Potential involvement of IL-17F in asthma. / Ota, Kyoko; Kawaguchi, Mio; Matsukura, Satoshi; Kurokawa, Masatsugu; Kokubu, Fumio; Fujita, Junichi; Morishima, Yuko; Huang, Shau Ku; Ishii, Yukio; Satoh, Hiroaki; Hizawa, Nobuyuki.

In: Journal of Immunology Research, Vol. 2014, 602846, 01.01.2014.

Research output: Contribution to journalReview article

Ota, K, Kawaguchi, M, Matsukura, S, Kurokawa, M, Kokubu, F, Fujita, J, Morishima, Y, Huang, SK, Ishii, Y, Satoh, H & Hizawa, N 2014, 'Potential involvement of IL-17F in asthma', Journal of Immunology Research, vol. 2014, 602846. https://doi.org/10.1155/2014/602846
Ota K, Kawaguchi M, Matsukura S, Kurokawa M, Kokubu F, Fujita J et al. Potential involvement of IL-17F in asthma. Journal of Immunology Research. 2014 Jan 1;2014. 602846. https://doi.org/10.1155/2014/602846
Ota, Kyoko ; Kawaguchi, Mio ; Matsukura, Satoshi ; Kurokawa, Masatsugu ; Kokubu, Fumio ; Fujita, Junichi ; Morishima, Yuko ; Huang, Shau Ku ; Ishii, Yukio ; Satoh, Hiroaki ; Hizawa, Nobuyuki. / Potential involvement of IL-17F in asthma. In: Journal of Immunology Research. 2014 ; Vol. 2014.
@article{93b592f4c13f43f582517f17cbf68aed,
title = "Potential involvement of IL-17F in asthma",
abstract = "The expression of IL-17F is seen in the airway of asthmatics and its level is correlated with disease severity. Several studies have demonstrated that IL-17F plays a pivotal role in allergic airway inflammation and induces several asthma-related molecules such as CCL20. IL-17F-induced CCL20 may attract Th17 cells into the airway resulting in the recruitment of additional Th17 cells to enhance allergic airway inflammation. We have recently identified, for the first time, that bronchial epithelial cells are its novel cell source in response to IL-33 via ST2-ERK1/2-MSK1 signaling pathway. The receptor for IL-17F is the heterodimeric complex of IL-17RA and IL-17RC, and IL-17F activates many signaling pathways. In a case-control study of 867 unrelated Japanese subjects, a His161 to Arg161 (H161R) substitution in the third exon of the IL-17F gene was associated with asthma. In atopic patients with asthma, prebronchodilator baseline FEV1/FVC values showed a significant association with the H161R variant. Moreover, this variant is a natural antagonist for the wild-type IL-17F. Moreover, IL-17F is involved in airway remodeling and steroid resistance. Hence, IL-17F may play an orchestrating role in the pathogenesis of asthma and may provide a valuable therapeutic target for development of novel strategies.",
author = "Kyoko Ota and Mio Kawaguchi and Satoshi Matsukura and Masatsugu Kurokawa and Fumio Kokubu and Junichi Fujita and Yuko Morishima and Huang, {Shau Ku} and Yukio Ishii and Hiroaki Satoh and Nobuyuki Hizawa",
year = "2014",
month = "1",
day = "1",
doi = "10.1155/2014/602846",
language = "English",
volume = "2014",
journal = "Journal of Immunology Research",
issn = "2314-8861",
publisher = "Hindawi Publishing Corporation",

}

TY - JOUR

T1 - Potential involvement of IL-17F in asthma

AU - Ota, Kyoko

AU - Kawaguchi, Mio

AU - Matsukura, Satoshi

AU - Kurokawa, Masatsugu

AU - Kokubu, Fumio

AU - Fujita, Junichi

AU - Morishima, Yuko

AU - Huang, Shau Ku

AU - Ishii, Yukio

AU - Satoh, Hiroaki

AU - Hizawa, Nobuyuki

PY - 2014/1/1

Y1 - 2014/1/1

N2 - The expression of IL-17F is seen in the airway of asthmatics and its level is correlated with disease severity. Several studies have demonstrated that IL-17F plays a pivotal role in allergic airway inflammation and induces several asthma-related molecules such as CCL20. IL-17F-induced CCL20 may attract Th17 cells into the airway resulting in the recruitment of additional Th17 cells to enhance allergic airway inflammation. We have recently identified, for the first time, that bronchial epithelial cells are its novel cell source in response to IL-33 via ST2-ERK1/2-MSK1 signaling pathway. The receptor for IL-17F is the heterodimeric complex of IL-17RA and IL-17RC, and IL-17F activates many signaling pathways. In a case-control study of 867 unrelated Japanese subjects, a His161 to Arg161 (H161R) substitution in the third exon of the IL-17F gene was associated with asthma. In atopic patients with asthma, prebronchodilator baseline FEV1/FVC values showed a significant association with the H161R variant. Moreover, this variant is a natural antagonist for the wild-type IL-17F. Moreover, IL-17F is involved in airway remodeling and steroid resistance. Hence, IL-17F may play an orchestrating role in the pathogenesis of asthma and may provide a valuable therapeutic target for development of novel strategies.

AB - The expression of IL-17F is seen in the airway of asthmatics and its level is correlated with disease severity. Several studies have demonstrated that IL-17F plays a pivotal role in allergic airway inflammation and induces several asthma-related molecules such as CCL20. IL-17F-induced CCL20 may attract Th17 cells into the airway resulting in the recruitment of additional Th17 cells to enhance allergic airway inflammation. We have recently identified, for the first time, that bronchial epithelial cells are its novel cell source in response to IL-33 via ST2-ERK1/2-MSK1 signaling pathway. The receptor for IL-17F is the heterodimeric complex of IL-17RA and IL-17RC, and IL-17F activates many signaling pathways. In a case-control study of 867 unrelated Japanese subjects, a His161 to Arg161 (H161R) substitution in the third exon of the IL-17F gene was associated with asthma. In atopic patients with asthma, prebronchodilator baseline FEV1/FVC values showed a significant association with the H161R variant. Moreover, this variant is a natural antagonist for the wild-type IL-17F. Moreover, IL-17F is involved in airway remodeling and steroid resistance. Hence, IL-17F may play an orchestrating role in the pathogenesis of asthma and may provide a valuable therapeutic target for development of novel strategies.

UR - http://www.scopus.com/inward/record.url?scp=84900312225&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84900312225&partnerID=8YFLogxK

U2 - 10.1155/2014/602846

DO - 10.1155/2014/602846

M3 - Review article

C2 - 24829928

AN - SCOPUS:84900312225

VL - 2014

JO - Journal of Immunology Research

JF - Journal of Immunology Research

SN - 2314-8861

M1 - 602846

ER -